Skandinaviska Enskilda Banken Ab (Publ) Merus N.V. Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $24.3 Billion
- Q3 2025
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Merus N.V. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 15,000 shares of MRUS stock, worth $1.43 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$1.43 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding MRUS
# of Institutions
229Shares Held
66.6MCall Options Held
311KPut Options Held
556K-
Paradigm Biocapital Advisors LP New York, NY4.28MShares$408 Million10.51% of portfolio
-
Rtw Investments, LP New York, NY4MShares$381 Million3.23% of portfolio
-
Wellington Management Group LLP Boston, MA3.73MShares$355 Million0.04% of portfolio
-
Commodore Capital LP New York, NY3.53MShares$336 Million17.29% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.38MShares$322 Million4.09% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $4.37B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...